Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001718626 | SCV000527250 | benign | not provided | 2020-02-06 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002314046 | SCV000848778 | likely benign | Inborn genetic diseases | 2017-01-17 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV000866738 | SCV001007873 | benign | Intellectual disability, autosomal dominant 6; Developmental and epileptic encephalopathy, 27 | 2024-01-24 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004734971 | SCV005350600 | likely benign | GRIN2B-related disorder | 2024-05-23 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |